• Placental ferroptosis and impaired fetal growth in symptomatic and asymptomatic SARS-CoV-2 infections. 01.05.2026

• Cirugía ortopédica en pacientes con infección por SARS-COV2. Experiencia en el Hospital Central Militar 19.04.2026

• Integrated experimental and computational evidence for Cymbopogon citratus as an anti-SARS-CoV-2 agent 19.04.2026

• Antibody profiling and plasma proteomics in SARS-CoV-2 infection:
  a pilot study 19.04.2026

• SARS-CoV-2 main protease inhibition by natural compounds 19.04.2026

• Peptide ligands to explore interactions with intrinsically disordered multidomain proteins:
  the case of SARS-CoV-2 nucleocapsid protein. 18.04.2026

• Correlates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccine. 18.04.2026

• Genetic polymorphisms and expression of SARS-CoV-2 host entry genes associate with COVID-19 severity in an unvaccinated Moroccan cohort. 18.04.2026

• Peptide ligands to explore interactions with intrinsically disordered multidomain proteins:
  the case of SARS-CoV-2 nucleocapsid protein 18.04.2026

• SARS-CoV-2:
  A microbiological perspective on characteristics and diagnosis 18.04.2026

• Investigation of Selected Biomolecules Potentially Effective in Inhibiting SARS-CoV-2 (COVID-19) through In Silico Analysis 18.04.2026

• Automated Leucocyte VCS Parameter Profiling for Differentiating SARS-CoV-2 and Dengue Infections:
  A Comparative Exploratory Study 18.04.2026

• Chip‐Based Digital PCR Approach for Improved SARS‐CoV‐2 Quantification for Endemic Wastewater Surveillance 18.04.2026

• Genetic polymorphisms and expression of SARS-CoV-2 host entry genes associate with COVID-19 severity in an unvaccinated Moroccan cohort 18.04.2026

• Non-canonical proteolytic activation of RNase L by SARS-CoV-2 3CLpro offsets inactivation of OAS1 p46 antiviral signaling 18.04.2026

• Immunosenescence and CMV-Associated Immune Signatures on SARS-CoV-2 Booster Responses. 17.04.2026

• Covalent conjugation of TLR9 agonists to phospholipids enhances mRNA-LNP delivery efficiency and dendritic cell cross-priming. 17.04.2026

• Designing effective SARS-CoV-2 wastewater surveillance system:
  lessons learnt from sustained monitoring in Delhi, India. 17.04.2026

• COVID-19 and risk of first-time major depressive disorder in patients without history of psychiatric disorders. 17.04.2026

• Viral variant but not host factors associate with SARS-CoV-2 viral kinetics. 17.04.2026

• Self-reported anxiety, depression, and health-related quality of life during two years following hospitalization for covid-19:
  a longitudinal study. 17.04.2026

• Distinct plasma proteome signature at 3 months post-COVID-19 infection irrespective of post-COVID condition. 17.04.2026

• Target Trial Emulation of Vaccine Effectiveness in 5- to 17-years-olds with Prior SARS-CoV-2 Infection. 17.04.2026

• Age-dependent clinical and molecular rhinovirus epidemiology, 2018 to 2023. 17.04.2026

• Distinct plasma cytokine and chemokine profiles in severe COVID-19 and septic shock. 17.04.2026

• Hybrid feature-selection and diversity-guided stacking framework for interpretable ensemble learning:
  Application to COVID-19 mortality prediction. 17.04.2026

• COVID-19 in hemodialysis patients:
  New insights into metabolomic profile dynamics from 60 days pre- to 60 days post-diagnosis. 17.04.2026

• New transcription signals in SARS-CoV-2 reshape virus-host interactions. 17.04.2026

• What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring. 17.04.2026

• Mapping global evidence on compassion fatigue among healthcare workers during COVID-19:
  insights and implications for future preparedness - a scoping review. 17.04.2026

• New transcription signals in SARS-CoV-2 reshape virus-host interactions. 17.04.2026

• Viral variant but not host factors associate with SARS-CoV-2 viral kinetics. 17.04.2026

• SARS-CoV-2 neutralising antibody profiles reveal variant specific antibody dynamics and regional differences in infection histories in Malawi 17.04.2026

• Does BA.3.2 epidemiology imply a change in SARS-CoV-2 evolution? 17.04.2026

• Modernising antiviral drug discovery:
  harnessing medicinal plants through machine learning and metabolomics to target the SARS-CoV-2 main protease 17.04.2026

• Targeting SARS-CoV-2 main protease (3CLpro) with Paeonia-derived phytochemicals 17.04.2026

• Comportamiento de la pubertad precoz central antes y durante la pandemia de SARS-CoV-2 17.04.2026

• Library preparation of SARS-CoV-2 RNA using Molecular Inversion Probes (MIPs) target capture for Whole Genome Sequencing (WGS) on Illumina platform v1 17.04.2026

• Combined Effects of Severe Immunocompromise and Prolonged Virus Shedding on Within-Host SARS-CoV-2 Evolution in COVID-19 17.04.2026

• The screening and identification of SARS-CoV-2 3CL protease inhibitors from Traditional Chinese Medicine using MALDI-TOF-MS 17.04.2026

• Deciphering SARS-CoV-2 EG.5:
  Advanced Molecular Docking and In-Silico Insights into Structural and Genetic Variations of Spike Protein Subvariants 17.04.2026

• Necrotising enterocolitis in infants with in‐utero SARS-CoV-2 exposure in Tshwane, South Africa 17.04.2026

• Maternal SARS-CoV-2 Infection and Early Child Growth and Development:
  A Nationwide Cohort Study 17.04.2026

• What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring 17.04.2026

• Target Trial Emulation of Vaccine Effectiveness in 5- to 17-years-olds with Prior SARS-CoV-2 Infection 17.04.2026

• Erratum:
  What Doesn’t Work in the European Cohesion Policy? Development Challenges of the Inner Periphery After the SARS-CoV-2 Pandemic 17.04.2026

• Simplified wastewater processing using ultrafiltration and dipstick-based RNA extraction for SARS-CoV-2 monitoring 17.04.2026

• Распространение вариантов вируса SARS-COV-2, вызывающих интерес (VOI) и находящихся под наблюдением (VUM), на основе количества их геномов, депонированных в базу данных GISAID за неделю с 11 по 17 апреля 2026 г. 17.04.2026

• Difference in neutralizing antibodies percentages against SARS-CoV-2 in vaccinated breastfeeding women’s milk and blood 17.04.2026

• Diferencia en los porcentajes de anticuerpos neutralizantes contra el SARS-CoV-2 en la leche y la sangre de mujeres lactantes vacunadas 17.04.2026

• P08-4 The association between socioeconomic status and SARS-CoV-2 infection and COVID-19-related mortality in the UK:
  a systematic review and meta-analysis 17.04.2026

• A cohort of cancer patients with no reported cases of SARS-CoV-2 infection:
  the possible preventive role of Methylene Blue 17.04.2026

• Considerations for Treating CoronaVirus (Sars-Cov-2) Infection with Passive Immunotherapy 17.04.2026

• The Concept of Organization and the Strategic Position of Chemistry in a Generic Research and Development Project Focused on SARS-CoV-2 17.04.2026

• Assessing Mass Screening as an Effective Tool for Pandemic Management:
  An Experimental Study of SARS-CoV-2 Diagnosis 17.04.2026

• Performance Evaluation of Meso Scale Discovery (MSD) quantitative serological assays for detection of binding (IgG, IgA, IgM) and ACE2 inhibitory antibody levels for SARS-CoV-2 17.04.2026

• Bayesian Analysis of NPI and Vaccination Effects on SARS-CoV-2 Transmission in South Korea 2020–2022 17.04.2026

• Designing effective SARS-CoV-2 wastewater surveillance system:
  lessons learnt from sustained monitoring in Delhi, India 17.04.2026

• Clinical features and disease severity across immune status in pediatric patients with COVID-19. 16.04.2026

• Epidemiological patterns of acute respiratory illnesses in a tertiary center in Riyadh, Saudi Arabia. 16.04.2026

• Epidemiology of pediatric invasive group A streptococcus infection in a Saudi tertiary care center. 16.04.2026

• OpenRecombinHunt:
  Automatic detection of recombination in publicly available viral sequences. 16.04.2026

• Slow PP(i) release enhances fidelity of the SARS-CoV-2 RNA dependent RNA polymerase. 16.04.2026

• Mapping immune imprinting zones enables predictive vaccination optimization. 16.04.2026

• RNA virus polymerase-helicase coupling enables rapid elongation through duplex RNA. 16.04.2026

• The immune response of the mRNA vaccine CS-2034 as a heterologous booster before and after breakthrough infection:
  A follow-up study. 16.04.2026

• Probiotics and Bacteriocins Against SARS-CoV-2:
  Therapeutic Frontiers and Mechanistic Insights. 16.04.2026

• Uncomplicated malaria as a risk factor for COVID-19 duration and severity in western Kenya and Burkina Faso (MALCOV):
  a prospective cohort study. 15.04.2026

• Immune responses associated with protection from SARS-CoV-2 infection. 13.04.2026

• Understanding the long-term neurological effects of SARS-CoV-2 infection. 13.04.2026

• Respiratory viruses as key drivers of pulmonary fibrosis:
  integrated pathways from barrier injury to immune-fibrotic crosstalk. 11.04.2026

• Diagnostic Performance Evaluation of the GXT96 X3 Extraction System with the FluoroType® SARS-CoV-2 varID Q Assay for Detection and Variant Identification of SARS-CoV-2 10.04.2026

• Differential outcomes of viral co-infections with high pathogenicity avian influenza A(H5N6) and SARS-CoV-2 in mammalian in vitro systems. 09.04.2026

• SARS-CoV-2 targets mitochondria, exacerbating COVID-19 pneumonia. 09.04.2026

• Immunological Dysfunction Associated with SARS-CoV-2 Persistence in Immunocompromised Patients. 08.04.2026

• Conserved stem-loops of the SARS-CoV-2 5’-UTR activate OAS1 02.04.2026

• Adolescent Cannabis Use After Cannabis Legalization and the COVID-19 Pandemic. 01.04.2026

• Lockdown COVID‑19:
  a stress test revealing more about the mental health system than psychopathology-A comparative analysis between Austria, Germany, and Italy. 01.04.2026

• Humoral immunity and infection status of PLWH following vaccination after the BA.5/BF.7 wave. 01.04.2026

• Investigation of mRNA expressions in nasopharyngeal and oropharyngeal swab samples in active SARS-CoV-2 infection and after SARS-CoV-2 infection. 26.03.2026

• Intrauterine SARS-CoV-2 Exposure and Infant Neurodevelopment. 19.03.2026

• Genome characterization of the SARS-CoV-2 omicron in Cameroon. 16.03.2026

• Loss of Infectivity of Influenza Virus and SARS-CoV‑2 during Aerosol Sampling 14.03.2026

• Anthropozoonotic spillovers reveal sustained long-term cryptic circulation of SARS-CoV-2 within and between Lithuanian mink farms. 13.03.2026

• The Feasibility of Developing a Universal SARS-CoV-2 Vaccine. 13.03.2026

• Anti-GQ1b-Positive Miller Fisher Syndrome Following Pfizer Bivalent COVID-19 Vaccination. 12.03.2026

• SARS-CoV-2 Infection and Vaccination, Immune Dysregulation, and Cancer. 11.03.2026

• Will animal reservoirs give us the next SARS-CoV-2 variant? 03.03.2026

• Viruses (Including SARS-CoV-2), Nematodes and Their Spread 02.03.2026

• Characteristics of SARS-CoV-2 transmission in Australia. 01.03.2026

• Wastewater Surveillance for SARS-CoV-2 in Rural Kentucky, 2021-2023. 26.02.2026

• Welding fumes and SARS-CoV-2:
  a dangerous combination. 25.02.2026

• A narrative review of SARS-CoV-2 variants and long COVID. 25.02.2026

• Impact of Smoking on Household SARS-CoV-2 Transmission. 22.02.2026

• Lymphopenia in Bacterial Sepsis and SARS-CoV-2 Infection. 15.02.2026

• Host Glycan-Lectin Interplay in SARS-CoV-2 Infection. 06.02.2026

• Impact of Smoking on Household SARS-CoV-2 Transmission 01.02.2026

• Therapeutic Approaches to Treat SARS-CoV-2. 01.02.2026

• Lymphopenia in Bacterial Sepsis and SARS-CoV-2 Infection 01.02.2026

• Genetic and Structural Analyses of Coronaviruses:
  Insights into SARS-CoV-2 and Beyond 01.02.2026

Quellen: PubMed, Europe PMC & CrossRef